| |
|
|
|
Eyepoint Pharmaceuticals Inc  
|
|
9.9 0.01 (0%) |
01-22 16:00 |
|
Open: |
9.64 |
Pre close: |
9.89 |
Target:
|
15.18
|
|
High: |
10.06 |
Low: |
9.06 |
Resistance:
|
13.00
15.18
|
|
Volume: |
199,260 |
Market Cap: |
180M |
Support:
|
7.66
4.36
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.32
 |
MACD |
MACD(12,26):
|
1.34 |
|
MA(20): |
8.77  |
Signal(12,26,9): |
1.39 |
|
MA(100): |
5.59 |
Stochastic Oscillator |
%K(14,3):
|
59.45 |
|
MA(250): |
8.11 |
%D(3): |
64.64 |
|
Average Volume(K) |
3-Month: |
27713
|
52-Week |
High:
|
21.00 |
|
10-Days: |
28479 |
Low: |
3.50 |
|
RSI |
RSI(14):
|
65.81 |
Change(%): |
-49.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.380 |
Return on Equity (ttm) |
-342.8 |
Shares Out. (M) |
18.14 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-26.4 |
Shares Float (M) |
10.27 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.73 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
525.5 |
% Held by Institutions |
46.62 |
|
Forward EPS |
-0.540 |
Gross Profit (p.s.) |
0.127 |
Shares Short (K) |
349 |
|
Book Value (p.s.) |
0.580 |
EBITDA (p.s.) |
-1.671 |
P/E |
-2.93 |
|
Sales Per Share |
1.981 |
Qtrly Earnings Growth |
0.00 |
P/BV |
17.07 |
|
Profit Margin |
-112.23 |
Operating Cash Flow
(M) |
-31.82 |
P/S |
5.00 |
|
Operating Margin |
-91.68 |
Levered Free Cash Flow
(M) |
-17.95 |
P/CF |
-5.64 |
|
|
|
|
|
|
